Status:
UNKNOWN
Topical Insulin Versus Autologous Serum After Corneal Surgeries
Lead Sponsor:
Benha University
Conditions:
Corneal Epithelial Wound
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The aim of the study is to test whether use of topical insulin or autologous serum eye-drops can promote corneal epithelial healing following photorefractive keratectomy (PRK).
Detailed Description
Topical insulin has been proved recently to enhance the corneal reepithelization rate and manage neurotrophic corneal ulcers unresponsive to conventional treatments. However, its effectiveness on corn...
Eligibility Criteria
Inclusion
- stable refraction of at least one year, normal corneal topography, and a minimum central corneal thickness of 500 μm.
Exclusion
- unstable refraction, dry eye, blepharitis, corneal disease, glaucoma, systemic diseases including infectious and collagen vascular diseases, diabetes, and topographical evidence of keratoconus.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05331859
Start Date
May 1 2022
End Date
September 1 2022
Last Update
April 22 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ebsar Eye Centre
Banhā, Kalyobeya, Egypt, 13512
2
Benha University
Banhā, Egypt, 13512